Voyageur Pharmaceuticals Ltd (V:VM) — Market Cap & Net Worth
Market Cap & Net Worth: Voyageur Pharmaceuticals Ltd (VM)
Voyageur Pharmaceuticals Ltd (V:VM) has a market capitalization of $21.32 Million (CA$29.47 Million) as of September 17, 2026. Listed on the V stock exchange, this Canada-based company holds position #24991 globally and #972 in its home market, demonstrating a -2.94% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Voyageur Pharmaceuticals Ltd's stock price CA$0.17 by its total outstanding shares 178586978 (178.59 Million). Also see Voyageur Pharmaceuticals Ltd total assets for a full breakdown of the balance sheet.
Voyageur Pharmaceuticals Ltd Market Cap History: 2015 to 2026
Voyageur Pharmaceuticals Ltd's market capitalization history from 2015 to 2026. Data shows growth from $12.92 Million to $21.32 Million (4.69% CAGR). Also see Voyageur Pharmaceuticals Ltd (VM) cash flow conversion for how efficiently the company converts equity into cash flow.
Voyageur Pharmaceuticals Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Voyageur Pharmaceuticals Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Voyageur Pharmaceuticals Ltd for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1879.49x
Voyageur Pharmaceuticals Ltd's market cap is 1879.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $21.96 Million | $11.69K | -$3.53 Million | 1879.49x | N/A |
Competitor Companies of VM by Market Capitalization
Companies near Voyageur Pharmaceuticals Ltd in the global market cap rankings as of September 17, 2026. Review Voyageur Pharmaceuticals Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Voyageur Pharmaceuticals Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Voyageur Pharmaceuticals Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Voyageur Pharmaceuticals Ltd's market cap moved from $12.92 Million to $ 21.32 Million, with a yearly change of 4.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$21.32 Million | -2.94% |
| 2025 | CA$21.96 Million | +100.00% |
| 2024 | CA$10.98 Million | +13.33% |
| 2023 | CA$9.69 Million | -11.76% |
| 2022 | CA$10.98 Million | -5.56% |
| 2021 | CA$11.63 Million | +28.57% |
| 2020 | CA$9.04 Million | -12.50% |
| 2019 | CA$10.33 Million | +14.29% |
| 2018 | CA$9.04 Million | -30.00% |
| 2017 | CA$12.92 Million | 0.00% |
| 2016 | CA$12.92 Million | 0.00% |
| 2015 | CA$12.92 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Voyageur Pharmaceuticals Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.32 Million USD |
| MoneyControl | $21.32 Million USD |
| MarketWatch | $21.32 Million USD |
| marketcap.company | $21.32 Million USD |
| Reuters | $21.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The co… Read more